From High- to Low-Frequency Administered Interferon-Beta for Multiple Sclerosis: A Multicenter Study

Publisher： Karger

E-ISSN： 1421-9913|71|5-6|233-241

ISSN： 0014-3022

Source： European Neurology, Vol.71, Iss.5-6, 2014-01, pp. : 233-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Interferon-beta-1b on Cognitive Functions in Multiple Sclerosis

By  

European Neurology, Vol. 47, Iss. 1, 2002-01 ,pp. : 11-14

Karger

Access to resources Recommend Favorite

The Treatment of Multiple Sclerosis with Beta-Interferon

By  

Neuroepidemiology, Vol. 31, Iss. 3, 2008-08 ,pp. : 157-158

Karger

Access to resources Recommend Favorite

Coping Strategy and Anxiety Evolution in Multiple Sclerosis Patients Initiating Interferon-Beta Treatment

By  

European Neurology, Vol. 62, Iss. 2, 2009-06 ,pp. : 79-85

Karger

Access to resources Recommend Favorite

Multiple Sclerosis-Associated Fatigue during Disease-Modifying Treatment with Natalizumab, Interferon-Beta and Glatiramer Acetate

By  

European Neurology, Vol. 65, Iss. 4, 2011-03 ,pp. : 231-232

Karger

Access to resources Recommend Favorite

Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland

By  

European Neurology, Vol. 63, Iss. 2, 2010-01 ,pp. : 101-106

Karger

Access to resources Recommend Favorite